Inventor
Anusha DIAS
Inventor
US
Overview
Patents· 25 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
A61KPreparations for medical, dental or toiletry purposes14%
C12YEnzymes10%
C07HSugars9%
C07KPeptides9%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture9%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
A01KAnimal husbandry1%
B01LChemical or physical laboratory apparatus for general use1%
PatentTitleYear
12,577,554Methods for purification of messenger RNA202612,553,043Methods and compositions for messenger RNA purification202612,552,858Methods and compositions for delivering mRNA coded antibodies202612,509,666MRNA therapy for phenylketonuria202512,421,538Quantitative assessment for cap efficiency of messenger RNA202512,410,422Methods for purification of messenger RNA202512,370,238Composition and methods for treatment of primary ciliary dyskinesia202512,239,735Lipid nanoparticles for delivering mRNA vaccines202512,234,446Methods for purification of messenger RNA202512,084,711Quantitative assessment for cap efficiency of messenger RNA202412,076,438Compositions, methods and uses of messenger RNA202412,060,381Methods for purification of messenger RNA202411,976,272Methods for purification of messenger RNA202411,920,182Quantitative assessment for cap efficiency of messenger RNA202411,884,692Methods for purification of messenger RNA202411,820,977Methods for purification of messenger RNA202311,771,653Lipid nanoparticles for delivering mRNA vaccines202311,771,652Lipid nanoparticles for delivering mRNA vaccines202311,692,189Methods for purification of messenger RNA202311,559,561Composition and methods for treatment of primary ciliary dyskinesia202311,560,562Large-scale synthesis of messenger RNA202311,377,642mRNA therapy for phenylketonuria202211,365,437Quantitative assessment for cap efficiency of messenger RNA202211,253,605Codon-optimized CFTR MRNA202211,173,190Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to TRANSLATE BIO INC (22)· patent assignee history
2021–2026Based in US· patent location history
2023–2025Patents assigned to SANOFI SA (3)· patent assignee history
2023–2025Based in FR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TRANSLATE BIO INC | 22 | 2021–2026 |
| SANOFI SA | 3 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 22 | 2021–2026 |
| FR | 3 | 2023–2025 |